LumiThera Acquires Diopsys

LumiThera Acquires MacuLogix Assets (AdaptDx Pro)

July 26, 2022

Medical Devices

LumiThera, through a wholly owned subsidiary, purchased the assets of MacuLogix, including the AdaptDx Pro dark adaptometer used for early diagnosis of dry age-related macular degeneration (AMD). The acquisition expands LumiThera's diagnostic and monitoring capabilities and complements its Valeda photobiomodulation treatment platform for dry AMD patients.

Caldera Medical Acquires UVision 360 and the LUMINELLE Product Family

October 8, 2024

Medical Devices

Caldera Medical has acquired UVision 360, the developer of the LUMINELLE hysteroscopy and cystoscopy systems, expanding its minimally invasive women's health device portfolio. The deal brings the LUMINELLE product family — including the new LUMINELLE Bx on-demand biopsy technology — into Caldera's commercial infrastructure to broaden office-based and surgical hysteroscopy capabilities.

DiscernDx Acquires Luminist Labs

April 29, 2020

Biotechnology

DiscernDx, a Palo Alto precision medicine company, has acquired Luminist Labs, a privately-held diagnostic platform developer focused on early detection and diagnosis of liver disease. The acquisition will integrate Luminist's data and platform into DiscernDx's multi-omics system to accelerate development of non-invasive diagnostic and prognostic solutions for NASH and other chronic metabolic liver diseases. Terms were not disclosed.

Boston Scientific Acquires Lumenis Surgical Business from Baring Private Equity Asia for $1.07B

March 3, 2021

Medical Devices

Boston Scientific has agreed to acquire the Lumenis Surgical Business from Baring Private Equity Asia/Lumenis for USD 1.07 billion, subject to closing adjustments. The deal transfers Lumenis' surgical laser portfolio and global surgical team (including its Israeli laser center of excellence) to Boston Scientific to bolster its Urology strategy, while Lumenis — still owned by BPEA — will focus on Aesthetics and Vision.

Somatus Acquires Strategic Assets from Lumiata

April 28, 2022

Healthcare Services

Somatus has acquired strategic assets from Lumiata to integrate Lumiata's healthcare AI and predictive analytics into Somatus' RenalIQ platform, improving early identification of people with chronic kidney disease and prediction of disease progression. The deal brings Lumiata talent (including Jessica McCarthy) into Somatus and aims to strengthen care delivery, reduce costs for provider and health-plan partners, and address health inequities.

Luminar Technologies Acquires OptoGration Inc.

July 19, 2021

Manufacturing

Luminar Technologies has acquired its exclusive InGaAs photodetector design partner and specialized fabrication partner, OptoGration Inc., securing chip IP and production capacity to support series production of its Iris lidar sensor. The deal brings OptoGration’s founders into Luminar, secures roughly one million InGaAs chips per year capacity (expandable), and deepens integration with Luminar’s Black Forest Engineering assets to accelerate production and reduce costs.